CD4 + CD25 + CD127 high cells as a negative predictor of multiple organ failure in acute pancreatitis

Wei Wang, He-Ping Xiang, Hui-Ping Wang, Li-Xin Zhu, Xiao-Ping Geng, Wei Wang, He-Ping Xiang, Hui-Ping Wang, Li-Xin Zhu, Xiao-Ping Geng

Abstract

Background: It has been suggested that severity of the immune response induced by immune cells is associated with morbidity and mortality from acute pancreatitis. The authors investigated and evaluated the relationship between distinct peripheral lymphocyte subsets at admission and clinical outcome prior to hospital discharge so as to find a predictor to the prognosis of acute pancreatitis in lymphocyte profile.

Methods: Lymphocyte subsets in admission peripheral venous blood were tested through flow cytometry on 48 patients with acute pancreatitis. Clinical data was recorded as well. The primary observational outcomes were multiple organ failure (MOF) and infection.

Results: There was a significant difference in natural killer cells between two subgroups sorted by the presence or absence of infection (25.5 ± 4.47 [95% CI 14.4, 36.6] vs 14.8 ± 7.62 [95% CI 12.5,1 7.1] p = 0.021). Patients who developed MOF had lower CD4 + CD25 + CD127high (4.49 ± 1.5 (MOF) [95% CI 3.83, 5.16] vs 6.57 ± 2.65 (non-MOF) [95% CI 5.5, 7.64] p = 0.002) and higher CD127low/high cell counts (1.35 ± 0.66 [95% CI 1.06, 1.65] vs 0.97 ± 0.44 [95% CI 0.79, 1.15] p = 0.02). MOF patients were significantly older (55 ± 14.58 [95% CI 48.49,61.42] vs 46 ± 15.59 [95% CI 39.39,51.99] p = 0.04), and had higher Acute Physiology and Chronic Health Evaluation IIscores (7 ± 3.66 [95% CI 5.5,7.64] vs 4 ± 2.89 [95% CI 2.45,4.78] p = 0.001) and C reactive protein (100.53 ± 94.38 [95% CI 58.69,142.48] vs 50.8 ± 59.2 [95% CI 26.88,74.71] p = 0.04). In a multivariate regression model, only CD4 + CD25 + CD127high cell was a significant predictor of non-MOF. For the detection of non-MOF, CD4 + CD25 + CD127high cell generated a receiver operating characteristic (ROC) curve with an area under the curve of 0.74.

Conclusion: CD4 + CD25 + CD127high cell at early phase of acute pancreatitis yields good specificity in detecting non-MOF at a suggested cutoff value 6.41%. Patients with fewer natural killer cells may be at risk in developing secondary infection.

Keywords: Acute pancreatitis; CD4 + CD25 + CD127high cell; Multiple organ failure; Natural killer cells; Prognosis; Regulatory T cell.

Figures

Fig. 1
Fig. 1
A 28-year-old man with acute necrotizing pancreatitis complicated by infected pancreatic necrosis requiring multiple percutaneous catheter drainage (red arrow in A and B). There is a large heterogeneous area of necrosis in the pancreatic and peri-pancreatic area with impacted gas bubbles (yellow ring in B)
Fig. 2
Fig. 2
Gating strategy of peripheral lymphocyte population (a) Gating strategy for CD4+ T cell subdivided into CD4 + CD25 + CD127low and CD4 + CD25 + CD127high subpopulation. B indicate lymphocyte divided from leukocyte based on forward scatter and side scatter, K indicate CD4+ T cells, G2 indicate CD4 + CD25 + CD127high cells and G4 CD4 + CD25 + CD127low cells. b Gating strategy for lymphocyte subdivided into T Helper cells, cytotoxic T cells and NK cells subpopulation. H indicate CD3+ T cells, F2 indicate CD3 + CD4+ T cells and J2 CD3 + CD8+ T cells, E1 indicate CD3-CD16 + CD56+ cells which were divided from CD3- T cells. c Gating strategy for B cells. C indicate lymphocyte divided from leukocyte according to CD45 and side scatter. D2 indicate CD19 + CD20 + CD45+ cells
Fig. 3
Fig. 3
mean NK cells percentage of lymphocytes at admission in infection group vs non- infection
Fig. 4
Fig. 4
ROC curve of CD4 + CD25 + CD127high cell in predicting non-MOF developing in the progress of acute pancreatitis
Fig. 5
Fig. 5
ROC curve of APACHEIIversus CRP in predicting MOF developing in the progress of acute pancreatitis

References

    1. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386:85–96. doi: 10.1016/S0140-6736(14)60649-8.
    1. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179–87. doi: 10.1053/j.gastro.2012.08.002.
    1. Gravante G, Garcea G, Ong SL, Metcalfe MS, Berry DP, Lloyd DM, et al. Prediction of mortality in acute pancreatitis: a systematic review of the published evidence. Pancreatology. 2009;9:601–14. doi: 10.1159/000212097.
    1. Dawra R, Sah RP, Dudeja V, Rishi L, Talukdar R, Garg P, et al. Intra-acinar trypsinogen activation mediates early stages of pancreatic injury but not inflammation in mice with acute pancreatitis. Gastroenterology. 2011;141:2210–7. doi: 10.1053/j.gastro.2011.08.033.
    1. Zheng L, Xue J, Jaffee EM, Habtezion A. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology. 2013;144:1230–40. doi: 10.1053/j.gastro.2012.12.042.
    1. Kylanpaa ML, Repo H, Puolakkainen PA. Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol. 2010;16:2867–72. doi: 10.3748/wjg.v16.i23.2867.
    1. Sun J, Bhatia M. Blockade of neurokinin-1 receptor attenuates CC and CXC chemokine production in experimental acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol. 2007;292:G143–53. doi: 10.1152/ajpgi.00271.2006.
    1. Zheng YS WZ, Zhang LY, Ke L, Li WQ, Li N, Li JS. Nicotine ameliorates experimental severe acute pancreatitis via enhancing immunoregulation of CD4+ CD25+regulatory T cells. Pancreas. 2015;44:500–6.
    1. Sarr MG, Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, et al. The new revised classification of acute pancreatitis 2012. Surg Clin North Am. 2013;93:549–62. doi: 10.1016/j.suc.2013.02.012.
    1. Working Group IAPAPAAPG. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013. doi:10.1016/j.pan.2013.07.063.
    1. Petrov MS, Shanbhag S, Chakraborty M, Phillips ARJ, Windsor JA. Organ Failure and Infection of Pancreatic Necrosis as Determinants of Mortality in Patients With Acute Pancreatitis. Gastroenterology. 2010;139:813–20. doi: 10.1053/j.gastro.2010.06.010.
    1. Liu Y, Wang L, Cai Z, Zhao P, Peng C, Zhao L, et al. The Decrease of Peripheral Blood CD4+ T Cells Indicates Abdominal Compartment Syndrome in Severe Acute Pancreatitis. PloS one. 2015. doi:10.1371/journal.pone.0135768.
    1. Freeman ML, Werner J, van Santvoort HC, Baron TH, Besselink MG, Windsor JA, et al. Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas. 2012;41:1176–94. doi: 10.1097/MPA.0b013e318269c660.
    1. Pezzilli R, Billi P, Gullo L, Beltrandi E, Maldini M, Mancini R, et al. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion. 1994;55:268–73. doi: 10.1159/000201159.
    1. Chinen T, Volchkov PY, Chervonsky AV, Rudensky AY. A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota. J Exp Med. 2010;207:2323–30. doi: 10.1084/jem.20101235.
    1. Jia W, Cao L, Yang S, Dong H, Zhang Y, Wei H, et al. Regulatory T cells are protective in systemic inflammation response syndrome induced by zymosan in mice. PloS one. 2013. doi:10.1371/journal.pone.0064936.
    1. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203:1701–11. doi: 10.1084/jem.20060772.
    1. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203:1693–700. doi: 10.1084/jem.20060468.
    1. Xue H, Wang W, Li Y, Shan Z, Li Y, Teng X, et al. Selenium upregulates CD4(+)CD25(+) regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD. H-2(h4) mice. Endocr J. 2010;57:595–601. doi: 10.1507/endocrj.K10E-063.
    1. Karrasch T, Brünnler T, Hamer OW, Schmid K, Voelk M, Herfarth H, et al. Soluble CD163 is increased in patients with acute pancreatitis independent of disease severity. Exp Mol Pathol. 2015;99:236–9. doi: 10.1016/j.yexmp.2015.07.006.
    1. Michel L, Berthelot L, Pettre S, Wiertlewski S, Lefrere F, Braudeau C, et al. Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. J Clin Invest. 2008;118:3411–9.
    1. Codarri L, Vallotton L, Ciuffreda D, Venetz JP, Garcia M, Hadaya K, et al. Expansion and tissue infiltration of an allospecific CD4 + CD25 + CD45RO + IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med. 2007;204:1533–41. doi: 10.1084/jem.20062120.
    1. Rehermann B. Natural Killer Cells in Viral Hepatitis. Cell Mol Gastroenterol Hepatol. 2015;1:578–88. doi: 10.1016/j.jcmgh.2015.09.004.
    1. Dabrowski A, Osada J, Dabrowska MI. Wereszczynska-Siemiatkowska U. Monocyte Subsets and Natural Killer Cells in Acute Pancreatitis. Pancreatology. 2008;8:126–34. doi: 10.1159/000123605.
    1. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet. 2008;371:143–52. doi: 10.1016/S0140-6736(08)60107-5.
    1. Rolle A, Pollmann J, Cerwenka A. Memory of infections: an emerging role for natural killer cells. PLoS Pathog. 2013. doi:10.1371/journal.ppat.1003548.

Source: PubMed

3
Se inscrever